Lymphocytotoxic antibodies in systemic lupus erythematosus: their clinical significance.
D000961:Antilymphocyte Serum / Q000276:immunology*; D001379:Azathioprine / Q000627:therapeutic use; D001666:Binding Sites, Antibody; D002493:Central Nervous System Diseases / Q000276:immunology; D003176:Complement C3; D003520:Cyclophosphamide / Q000627:therapeutic use; D003602:Cytotoxicity, Immunologic; D004247:DNA / Q000276:immunology; D006801:Humans; D007958:Leukocyte Count; D008180:Lupus Erythematosus, Systemic / Q000276:immunology*; D008214:Lymphocytes; D011241:Prednisone / Q000627:therapeutic use; D012877:Skin Manifestations
D000961:Antilymphocyte Serum; D003176:Complement C3; D003520:Cyclophosphamide; D004247:DNA; D001379:Azathioprine; D011241:Prednisone